Establishment Labs Holdings Inc
ESTA
Market Cap$1.56B
Close$
$56.38
2.7% downside
Current Fair Value
2.7% downsideOvervalued by 2.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.56 Billion |
|---|---|
| Enterprise Value | $1.68 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-3.07 |
| Beta | 2.12 |
| Outstanding Shares | 27,459,680 |
| Avg 30 Day Volume | 284,274 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -19.88 |
|---|---|
| PEG | -55.73 |
| Price to Sales | 11.59 |
| Price to Book Ratio | 28.98 |
| Enterprise Value to Revenue | 10.8 |
| Enterprise Value to EBIT | -25.62 |
| Enterprise Value to Net Income | -21 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 3.43 |
Revenue Sources
No data
ESG Score
No data
About Establishment Labs Holdings Inc
521 employees
CEO: Juan Jose Chacon Quiros Establishment Labs Holdings Inc. is a global medical technology company focused on women's health, initially in the breast aesthetics and reconstruction market, by designing, developing, manufacturing and marketing an innovative portfoli...